Skip navigation

Navigate the Evolving Healthcare Landscape, Sustain Specialty Drug Pricing and Maximize Product Access

August 16-17, 2017
  • Philadelphia, PA

Hundreds of leaders in Access, Reimbursement, Managed Markets and Commercial Operations have benefited from CBI’s Reimbursement and Access Congress. Now in its 5th year, this highly-acclaimed event addresses the challenges bio/pharma manufacturers face around regulatory hurdles, drug price scrutiny and demonstrating product value. Benefit from invaluable learning and benchmarking, covering the most impactful pricing and reimbursement trends and access strategies!

CLE & CPE
Credits
Available! Pending Approval

Interactive Panels, Compelling Sessions and Expert Insights on the Most Pressing Issues:

  • Marketplace changes impacting specialty drug management
  • 340B’s growing role in reimbursement and access and future policy
  • Innovative opportunities to focus on the value of specialty products
  • Global trends influencing payer decision-making and market access
  • Specialty drug utilization management and cost containment
  • Approaches and attributes for value proposition enhancement
  • Hub and SPP models to streamline processes and support access

Benefit From Two Tracks of Tailored Content:

I Payer Strategies and Reimbursement
II Access and Affordability

Previous Attendee Acclaim:

CBI ran a brilliant conference and their team were very supportive to me as a speaker. I would rate them
100% on their events.

Visiting Lecturer, Value-Based Pricing and Innovative Contracting, University of Portsmouth; Member, NICE Adoption and Impact Programme Reference Panel

Great opportunity to network and meet new folks.
I enjoyed being forced to think about what would
engage folks in this area as well.

Vice President, Market Access, ZS Pharma, Inc

Great attendance at this year’s event with plenty
to learn and discuss!

Vice President and Head, Health Economics and Outcomes Research, EMD Serono

I really enjoyed the opportunity to challenges my own thinking and organize my thoughts around a topic of key interest, and to engagement with others in the industry
to hear their perspectives on the same issues.

Principal, Strategic Health Policy Solutions LLC

Great topics areas and questions from the audience
in addition to a balance of perspectives...

Vice President, Policy, AHIP

Good business/landscape insights relevant to
today’s challenges, opportunities, etc.

Senior Marketing Manager, AbbVie

August 16-17, 2017 | Philadelphia, PA

Reimbursement and Access 2017

Navigate the Evolving Healthcare Landscape, Sustain Specialty Drug Pricing and Maximize Product Access

Hundreds of leaders in Access, Reimbursement, Managed Markets and Commercial Operations have benefited from CBI’s Reimbursement and Access Congress. Now in its 5th year, this highly-acclaimed event addresses the challenges bio/pharma manufacturers face around regulatory hurdles, drug price scrutiny and demonstrating product value. Benefit from invaluable learning and benchmarking, covering the most impactful pricing and reimbursement trends and access strategies!

CLE & CPE
Credits
Available! Pending Approval

Interactive Panels, Compelling Sessions and Expert Insights on the Most Pressing Issues:

  • Marketplace changes impacting specialty drug management
  • 340B’s growing role in reimbursement and access and future policy
  • Innovative opportunities to focus on the value of specialty products
  • Global trends influencing payer decision-making and market access
  • Specialty drug utilization management and cost containment
  • Approaches and attributes for value proposition enhancement
  • Hub and SPP models to streamline processes and support access

Benefit From Two Tracks of Tailored Content:

I Payer Strategies and Reimbursement
II Access and Affordability

Previous Attendee Acclaim:

CBI ran a brilliant conference and their team were very supportive to me as a speaker. I would rate them
100% on their events.

Visiting Lecturer, Value-Based Pricing and Innovative Contracting, University of Portsmouth; Member, NICE Adoption and Impact Programme Reference Panel

Great opportunity to network and meet new folks.
I enjoyed being forced to think about what would
engage folks in this area as well.

Vice President, Market Access, ZS Pharma, Inc

Great attendance at this year’s event with plenty
to learn and discuss!

Vice President and Head, Health Economics and Outcomes Research, EMD Serono

I really enjoyed the opportunity to challenges my own thinking and organize my thoughts around a topic of key interest, and to engagement with others in the industry
to hear their perspectives on the same issues.

Principal, Strategic Health Policy Solutions LLC

Great topics areas and questions from the audience
in addition to a balance of perspectives...

Vice President, Policy, AHIP

Good business/landscape insights relevant to
today’s challenges, opportunities, etc.

Senior Marketing Manager, AbbVie

August 16-17, 2017 | Philadelphia, PA